Abstract 13985: Targeting the Activin Receptor Type IIA for Therapeutics in Atrial Fibrillation
2021
Introduction: Atrial fibrillation (AF) is the most common cardiac arrhythmia and a leading cause of stroke and heart failure. However, limited treatment options are available. The adipo-fibrokine A...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI